Visit/event: | Enrolment visita | Intervention period | Follow-up visitsb | |||
---|---|---|---|---|---|---|
Baseline | Allocation | 1 | 2 | 3 | ||
Target chronology (days, weeks, months) | D0 | D0 (after baseline) | D1–D60 | M1c (D28–D60) | M6 ± 4 W | M12 ± 4 W |
Enrolment and allocation | ||||||
First study presentation and consent 1 | ✓ | |||||
Randomisation | ✓ | |||||
For those patients randonmised to the experimental arm, presentation of additional spa-treatment and consent 2 | ✓ | |||||
Interventions | ||||||
Explanation about low back pain and home exercise training for all patients | ✓ | |||||
Daily exercises at home using the “back book” for all patientsd | Throughout intervention and follow-up periods | |||||
Eighteen consecutive days of spa-therapy (except Sundays) for patients in the experimental arm | ✓ | |||||
Observance | ||||||
Home exercise observance | ✓ | ✓ | ✓ | |||
Spa therapy observance (experimental arm only) | ✓ | |||||
Harms | ||||||
Tolerance: adverse event characterisation and reporting | Throughout intervention and follow-up periods | |||||
Assessments | ||||||
Demographics and disease historye | ✓ | |||||
Visual analogue scale for low back pain | ✓ | ✓ | ✓ | ✓ | ||
The Rolland and Morris (RMDQ) scale | ✓ | ✓ | ✓ | ✓ | ||
The FABQ | ✓ | ✓ | ✓ | ✓ | ||
The EQ-5D-5L questionnaire | ✓ | ✓ | ✓ | ✓ | ||
Patient Acceptable Symptom State | ✓ | ✓ | ✓ | ✓ | ||
Global opinions on state of healthf | ✓ | ✓ | ✓ | ✓ | ||
Drug consumption in the past 72 h | ✓ | ✓ | ✓ | ✓ | ||
Health resource use since last visitg | ✓ | ✓ | ✓ | |||
Cost of careh | ✓ | |||||
Blinding success | ||||||
Guess-the-group question for evaluators | ✓ |